0 CHECKOUT

Bahrain Pharmaceuticals and Healthcare Report Q4 2015

  • ID: 3388412
  • September 2015
  • Region: Bahrain
  • 103 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • Al-Jishi Corporation
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck & Co
  • Novartis
  • Pfizer
  • MORE

Bahrain's government will continue in its attempts at containing the rapidly expanding cost of healthcare. Private sector engagement and increasing generic substitution will continue to be employed,
although government spending on the sector will continue to increase given its importance in social stability. The uptake of compulsory health insurance and increased government spending will continue to drive growth within the pharmaceutical market, with drugmakers viewing Bahrain as a small, but attractive market.

Headline Expenditure Projections
- Pharmaceuticals: BHD122mn (USD324mn) in 2014 to BHD131mn (USD347mn) in 2015; +7.2% in both local currency and US dollar terms. Forecast revised upwards from last quarter.

- Healthcare: BHD586mn (USD1.55bn) in 2014 to BHD635mn (USD1.69bn) in 2015; +8.5% in both local currency and US dollar terms. Forecast in line with last quarter.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Al-Jishi Corporation
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck & Co
  • Novartis
  • Pfizer
  • MORE

SWOT

Political

Economic

Operational Risk

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Bahrain 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Bahrain 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Bahrain 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Bahrain 2011-2019)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Bahrain 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Bahrain 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Bahrain 2011-2019)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Bahrain 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Bahrain 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Bahrain 2013-2019)

Key Risks To Forecast Scenario

Macroeconomic Forecasts

Economic Analysis
Table: BMI And Bloomberg Consensus Forecasts - Brent
Table: Bahrain - Real Gdp Growth, % Chg Y-O-Y

Expenditure Breakdown
Table: Bahrain - Main Infrastructure And Industrial Developments

Industry Risk Reward Indices

Middle East and Africa Risk/Reward Index - Q4 2015

Bahrain Risk/Reward Index

Rewards

Risks

Market Overview

Industry Trends And Developments

Epidemiology

Non-Communicable Diseases

Healthcare Sector

Healthcare Sector Developments

Healthcare Provision
Table: Ministry Of Health's Objectives

Health Insurance

Health Insurance For Expatriates
Table: National Health Insurance Scheme Breakdown

Healthcare Sector Investment

Information Technology In Healthcare

Research And Development

Clinical Trials

Regulatory Development

GCC Harmonisation

GCC Unified Drug Pricing System

Healthcare For Expatriates

Intellectual Property Regime

Counterfeit Medicines

Pricing And Reimbursement Regime

Public Sector Procurement

Free Trade Agreements

Competitive Landscape

Pharmaceutical Industry

Domestic Industry

Pharmaceutical Industry Developments

Pharmaceutical Retail

Company Profile

Al-Jishi Corporation

Bahrain Industrial Pharmaceutical Co (Bidapharm)

Behzad Medical Establishment

GlaxoSmithKline

Johnson & Johnson

Merck & Co

Novartis

Pfizer

Sanofi

Yousuf Mahmood Husain Company

Demographic Forecast
Table: Population Headline Indicators (Bahrain 1990-2025)
Table: Key Population Ratios (Bahrain 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Bahrain 1990-2025)
Table: Population By Age Group (Bahrain 1990-2025)
Table: Population By Age Group % (Bahrain 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

Al-Jishi Corporation
Bahrain Industrial Pharmaceutical Co (Bidapharm)
Behzad Medical Establishment
GlaxoSmithKline
Johnson & Johnson
Merck & Co
Novartis
Pfizer
Sanofi
Yousuf Mahmood Husain Company

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.